Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ASV”

78 trials

Showing 20 of 78 results

Large-scale testing (Phase 3)Study completedNCT02170727
What this trial is testing

A Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Subjects With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 199
Not applicableLooking for participantsNCT06178510
What this trial is testing

I-ASV in Cardiac Surgery

Who this might be right for
Ventilator Lung
Medical University of Vienna 328
Not applicableWithdrawnNCT02762448
What this trial is testing

Interferon-free Antiviral Treatment of HCV-Positive Genotype 1b Related Indolent Non-Hodgkin Lymphomas

Who this might be right for
Hepatitis c
Tainan Municipal Hospital
Large-scale testing (Phase 3)Study completedNCT01979939
What this trial is testing

UNITY 1: A Study of an Investigational Treatment Regimen of Daclatasvir (DCV) + Asunaprevir (ASV) + BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) for 12 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Genotype 1 Infection in Non-cirrhotic Subjects

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 416
Not applicableStudy completedNCT04873336
What this trial is testing

Closed Loop Ventilation in Patients With COVID-19

Who this might be right for
Covid19ARDS
Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital 20
Not applicableStudy completedNCT02250001
What this trial is testing

Asunaprevir/Daclatasvir Safety Surveillance in Japanese Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 2,974
Not applicableLooking for participantsNCT02919930
What this trial is testing

Interface Selection for Adaptive Servo Ventilation

Who this might be right for
Central Sleep ApneaASV
Universitaire Ziekenhuizen KU Leuven 15
Testing effectiveness (Phase 2)Study completedNCT01455090
What this trial is testing

Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 320
Early research (Phase 1)Study completedNCT02045966
What this trial is testing

Study to Determine the Potential DDIs When the Daclatasvir/Asunaprevir/BMS-791325 Three Drug Antiviral Combination Tablet (FDC) is Coadministered With a Cocktail of Cytochrome P450 (CYP) Probe Substrates and Transporter Probe Substrates (Digoxin and Pravastatin) in Healthy Subjects

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 16
Early research (Phase 1)Study completedNCT02095860
What this trial is testing

Food Effect of a Fixed Dose Combination of Daclatasvir, Asunaprevir and BMS-791325

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 24
Large-scale testing (Phase 3)Study completedNCT01573351
What this trial is testing

Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials)

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 398
Not applicableStudy completedNCT01462084
What this trial is testing

Effectiveness of Adaptive Servoventilation (ASV) in Patients With Central Sleep Apnea Due to Chronic Opioid Use

Who this might be right for
Obstructive Sleep ApneaCentral Sleep Apnea (Diagnosis)Chronic Opioid Use
ResMed 21
Post-approval studies (Phase 4)UnknownNCT02639585
What this trial is testing

Efficacy and Safety of Daclatasvir Plus Asunaprevir in Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Pusan National University Hospital 32
Large-scale testing (Phase 3)Study completedNCT01973049
What this trial is testing

UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 202
Not applicableStudy completedNCT01492504
What this trial is testing

Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 1,850
Testing effectiveness (Phase 2)Study completedNCT01030432
What this trial is testing

Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 285
Testing effectiveness (Phase 2)Study completedNCT01428063
What this trial is testing

Study of pegInterferon Alfa-2a, Ribavirin, and Daclatasvir (BMS-790052) With or Without BMS-650032 for Participants in Some Hepatitis C Virus Trials

Who this might be right for
Hepatitis C Virus Infection
Bristol-Myers Squibb 276
Testing effectiveness (Phase 2)Study completedNCT01795911
What this trial is testing

Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 165
Large-scale testing (Phase 3)Study completedNCT03004625
What this trial is testing

Daclatasvir, Asunaprevir Plus Ribavirin for HCV Genotype 1b Without NS5A RAV

Who this might be right for
Hepatitis C
Kaohsiung Medical University Chung-Ho Memorial Hospital 70
Early research (Phase 1)Study completedNCT01019070
What this trial is testing

Hepatic Impaired Subjects Compared to Healthy Subjects Receiving Multi-dose BMS-650032

Who this might be right for
Hepatic Insufficiency
Bristol-Myers Squibb 28
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation